tiprankstipranks
Trending News
More News >
Karyopharm Therapeutics (KPTI)
NASDAQ:KPTI
US Market
Advertisement

Karyopharm Therapeutics (KPTI) Technical Analysis

Compare
1,200 Followers

Technical Sentiment

Overall Consensus
Buy
10Bullish
6Neutral
6Bearish
Technical Analysis Consensus
Buy
4Bullish
6Neutral
0Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Karyopharm Therapeutics’s (KPTI) Moving Averages Convergence Divergence (MACD) indicator is 0.66, suggesting Karyopharm Therapeutics is a Buy.
Karyopharm Therapeutics’s (KPTI) 20-Day exponential moving average is 6.22, while Karyopharm Therapeutics’s (KPTI) share price is $6.6, making it a Buy.
Karyopharm Therapeutics’s (KPTI) 50-Day exponential moving average is 5.46, while Karyopharm Therapeutics’s (KPTI) share price is $6.6, making it a Buy.

Karyopharm Therapeutics (KPTI) Pivot Points

Sep 06, 2025, 06:12 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
6.10
6.40
6.57
6.87
7.04
7.34
7.51
Fibonacci
6.40
6.58
6.69
6.87
7.05
7.16
7.34
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Karyopharm Therapeutics (KPTI) Moving Averages

Sep 06, 2025, 06:12 PM
Period
Simple
Exponential
MA5
6.86Sell
6.83Sell
MA10
6.99Sell
6.73Sell
MA20
6.05Buy
6.22Buy
MA50
4.99Buy
5.46Buy
MA100
5.05Buy
5.60Buy
MA200
6.99Sell
7.37Sell
Karyopharm Therapeutics’s (KPTI) 10-Day exponential moving average is 6.73, while Karyopharm Therapeutics’s (KPTI) share price is $6.6, making it a Sell.
Karyopharm Therapeutics’s (KPTI) 100-Day exponential moving average is 5.60, while Karyopharm Therapeutics’s (KPTI) share price is $6.6, making it a Buy.
Karyopharm Therapeutics’s (KPTI) stock price is $6.6 and Karyopharm Therapeutics’s (KPTI) 50-day simple moving average is 4.99, creating a Buy signal.
Karyopharm Therapeutics’s (KPTI) stock price is $6.6 and Karyopharm Therapeutics’s (KPTI) 100-day simple moving average is 5.05, creating a Buy signal.
Karyopharm Therapeutics’s (KPTI) stock price is $6.6 and Karyopharm Therapeutics’s (KPTI) 200-day simple moving average is 6.99, creating a Sell signal.

Karyopharm Therapeutics (KPTI) Technical Indicators

Sep 06, 2025, 06:12 PM
Name
Value
Implied Action
RSI (14)
57.69
Neutral
STOCH (9,6)
35.88
Neutral
STOCHRSI (14)
57.78
Neutral
MACD (12,26)
0.66
Buy
ADX (14)
43.05
Neutral
Williams %R
-58.27
Buy
CCI (14)
44.82
Neutral
ATR (14)
0.58
-
Ultimate Oscillator
36.75
Neutral
ROC
11.49
Buy
Karyopharm Therapeutics’s (KPTI) Relative Strength Index (RSI) is 57.69, creating a Neutral signal.
Karyopharm Therapeutics’s (KPTI) Trend Strength Indicator (ADX) is 43.05, creating a Neutral signal.
Karyopharm Therapeutics’s (KPTI) Commodity Channel Index (CCI) is 44.82, creating a Neutral signal.
Karyopharm Therapeutics’s (KPTI) Price Rate of Change (ROC) is 11.49, creating a Buy signal.

FAQ

Is KPTI a Buy, Hold, or Sell?
Based on KPTI’s technical indicators, KPTI is a Buy.
    What is KPTI’s RSI (14)?
    KPTI’s RSI (14) is 57.69, which suggests KPTI is a Neutral.
      What is KPTI’s MACD?
      KPTI’s MACD is 0.66, which suggests KPTI is a Buy.
        What is KPTI’s 5-day moving average?
        KPTI’s 5-day moving average is 6.86, which suggests KPTI is a Sell.
          What is KPTI’s 20-day moving average?
          KPTI 20-day moving average is 6.05, which suggests KPTI is a Buy.
            What is KPTI’s 50-day moving average?
            KPTI’s 50-day moving average is 4.99, which suggests KPTI is a Buy.
              What is KPTI’s 200-day moving average?
              KPTI’s 200-day moving average is 6.99, which suggests KPTI is a Sell.
                What is KPTI’s Williams % R (14)?
                KPTI’s Williams % R (14) is -58.27, which suggests KPTI is a Buy.
                  What is KPTI’s CCI (14)?
                  KPTI’s CCI (14) is 44.82, which suggests KPTI is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis